This is reflected in the mean palbociclib-mediated tumor growth inhibition in each group of mice at every timepoint investigated, where the palbociclib effect on tumor growth inhibition is significantly greater in TGFB3-overexpressing tumors as compared to control mice during the entire experiment (Fig. 3c). Here, TGFB3 is linked to neoplasm.